Stem cell transplants now available on NHS for adults with thalassaemia
The NHS has announced the provision of stem cell transplants for adult patients battling severe inherited blood disorders, particularly thalassaemia.
Stem cell transplants are a...
New study findings could develop more effective treatments for depression and ADHD
A groundbreaking University of Surrey study has unveiled a critical factor that significantly influences the effectiveness of treatments for depression and ADHD: the patient's...
New Cancer Research UK manifesto aims to avoid 20,000 UK cancer deaths per year
Cancer Research UK has launched a new manifesto urging the next UK Government to take action to prevent 20,000 avoidable UK cancer deaths annually...
NHS approves life-saving Sebelipase alfa treatment for Wolman disease
The NHS has approved a life-saving treatment for babies and toddlers grappling with a rare and fatal genetic condition known as Wolman disease.
This marks...
WHO urges to combat the effects of climate change on human health ahead of...
In anticipation of the forthcoming UN Climate Change Conference (COP-28), the World Health Organization (WHO) has released its "2023 review of health in nationally...
New NHS software will improve care for millions of patients
New NHS software will deliver better care for millions of patients, help tackle waiting lists, and reduce hospital discharge delays.
New survey reveals one in five children and young people had a probable mental...
A report has revealed that one in five children and young people in England aged eight to 25 had a probable mental disorder in 2023.
Reframing the narrative about population ageing
Population ageing is a natural part of demographic development, so why is it increasingly seen as a burden?
We discuss population ageing with Joan Costa-i-Font,...
NHS extends COVID-19 OpenSAFELY research platform to develop new disease treatments
The NHS is embarking on a pioneering initiative to expand the groundbreaking OpenSAFELY research platform to propel advancements to combat other significant diseases.
Collaborating with...
Defence Therapeutics applies to use AccuTOX® as an advanced tumour treatment
Defence Therapeutics has submitted an Investigational New Drug application for AccuTOX®, an injectable anticancer molecule.
Familial hypercholesterolaemia identified through genetic testing
Genetic testing can identify patients with familial hypercholesterolaemia to prevent heart attack, stroke, and death.
We must adapt for an ageing population, says Chief Medical Officer
The CMO's new annual report says adapting for an ageing population should be a major aim of policy and medical practice. Read more here.
NHS emergency care continues to experience record demand
New data shows that NHS emergency care had the busiest October on record, with Type 1 attendances facing the busiest month so far this year.
Defence Therapeutics awarded CIPO patent for vaccine technology
Defence Therapeutics has announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice of Allowance for the company's Canadian patent application no....
Our Future Health: UK’s largest health research project reaches one million volunteers
Our Future Health – the largest ever health research programme in the UK – has announced its millionth volunteer has signed up to the project.
Newly discovered gene may trigger treatment-resistant major depressive disorder
In a groundbreaking study, researchers have uncovered a gene that interacts with stress, mediating certain aspects of treatment-resistant major depressive disorder.
Major depressive disorder is...
Combatting bullying in the NHS could save the health service £2.8bn
New research led by the University of Surrey has found that Bullying in the NHS costs the health service £2.8bn each year.
400,000 patients may travel for treatments to cut NHS waiting lists
In a bid to cut NHS waiting lists, hundreds of thousands of patients will be offered the opportunity to travel to different hospitals to...
RECOVERY trial set to investigate revolutionary new flu treatments
The groundbreaking RECOVERY trial, celebrated for its discovery of four effective treatments for COVID-19, is broadening its horizons by venturing into the realm of...
Dementia incidence rate increased in England and Wales after 2008
By studying the dementia incidence rate since 2008, a UCL-led study has found that up to 1.7 million people could be living with dementia...